MAIDA ANTHONY E III 4
4 · SPECTRUM PHARMACEUTICALS INC · Filed May 31, 2019
Insider Transaction Report
Form 4
MAIDA ANTHONY E III
Director
Transactions
- Sale
Common Stock, $0.001 par value
2019-05-29$7.75/sh−42,643$330,355→ 29,607 total - Exercise/Conversion
Common Stock, $0.001 par value
2019-05-29$6.09/sh+50,000$304,500→ 72,250 total - Exercise/Conversion
Stock Option Exercise (Right to Buy)
2019-05-29−50,000→ 0 totalExercise: $6.09From: 2012-06-26Exp: 2019-06-26→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]This transaction represents an open market sale of a portion of the expiring stock options exercised on this Form 4 to satisfy the Reporting Person's payment of the exercise price and the taxes associated with such exercise.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.695 to $7.82, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.